Outlook Therapeutics (OTLK) Short Interest Ratio & Short Volume $5.35 +0.08 (+1.52%) (As of 10/24/2024 ET) Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Outlook Therapeutics Short Interest DataOutlook Therapeutics (OTLK) has a short interest of 2.95 million shares, representing 19.37% of the float (the number of shares available for trading by the public). This marks a 19.43% increase in short interest from the previous month. The short interest ratio (days to cover) is 13.2, indicating that it would take 13.2 days of the average trading volume of 257,155 shares to cover all short positions.Current Short Interest2,950,000 sharesPrevious Short Interest2,470,000 sharesChange Vs. Previous Month+19.43%Dollar Volume Sold Short$15.75 millionShort Interest Ratio13.2 Days to CoverLast Record DateSeptember 30, 2024Outstanding Shares23,660,000 sharesFloat Size15,230,000 sharesShort Percent of Float19.37%Today's Trading Volume177,881 sharesAverage Trading Volume257,155 sharesToday's Volume Vs. Average69% Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartOTLK Short Interest Over TimeOTLK Days to Cover Over TimeOTLK Percentage of Float Shorted Over Time Ad Porter & CompanyUrgent: This election is riggedIf you missed it, my emergency election broadcast is now available - but will be removed soonClick here to watch it now. Outlook Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 9/30/20242,950,000 shares $15.75 million +19.4%19.4%13.2 $5.34 9/15/20242,470,000 shares $15.98 million +1.7%16.2%10.8 $6.47 8/31/20242,430,000 shares $17.86 million No Change15.9%12 $7.35 8/15/20242,430,000 shares $18.66 million +4.7%16.0%11.5 $7.68 7/31/20242,320,000 shares $17.98 million +8.4%15.5%9.8 $7.75 7/15/20242,140,000 shares $18.08 million +9.7%14.3%9 $8.45Election warning coming true… (Ad)If you missed it, my emergency election broadcast is now available - watch it before it's too late.Click here to watch it now. 6/30/20241,950,000 shares $14.39 million +18.2%13.0%7.8 $7.38 6/15/20241,650,000 shares $12.66 million -0.6%9.7%4.8 $7.67 5/31/20241,660,000 shares $11.74 million +24.8%10.0%2.4 $7.07 5/15/20241,330,000 shares $9.88 million +5.6%8.0%2 $7.43 4/30/20241,260,000 shares $11.24 million +11.5%7.7%2 $8.92 4/15/20241,130,000 shares $9.74 million -15.0%7.4%1.8 $8.62 3/31/20241,330,000 shares $15.88 million +69.4%6.2%2.2 $11.94 3/15/2024785,300 shares $6.47 million -93.3%10.6%1.6 $8.24 2/29/202411,640,000 shares $5.08 million -11.8%7.9%6 $0.44 2/15/202413,200,000 shares $6.40 million -2.7%9.0%6.5 $0.48 1/31/202413,570,000 shares $5.24 million +11.9%9.2%5.9 $0.39 1/15/202412,130,000 shares $4.47 million +7.3%9.2%1.9 $0.37 12/31/202311,310,000 shares $4.46 million +3.3%8.6%1.6 $0.39 12/15/202310,950,000 shares $4.20 million -32.1%8.3%1.5 $0.38 11/30/202316,130,000 shares $7.74 million -21.5%12.2%2.1 $0.48 11/15/202320,540,000 shares $9.16 million -35.9%16.0%1.8 $0.45 10/31/202332,030,000 shares $19.22 million +9.4%25.0%2.8 $0.60 10/15/202329,270,000 shares $9.51 million +9.5%22.9%3.2 $0.33 9/30/202326,720,000 shares $5.91 million +3.4%20.9%4.5 $0.22 9/15/202325,850,000 shares $5.56 million -3.0%20.2%4.6 $0.22 8/31/202326,660,000 shares $6.08 million +52.3%21.1%5.2 $0.23 8/15/202317,510,000 shares $27.14 million +4.9%13.9%12.2 $1.55 7/31/202316,700,000 shares $28.89 million +1.8%13.4%13.1 $1.73 7/15/202316,410,000 shares $27.08 million -2.2%13.2%13.2 $1.65 6/30/202316,770,000 shares $29.18 million -1.9%13.5%15.2 $1.74 6/15/202317,100,000 shares $30.44 million +3.9%13.7%16.6 $1.78 5/31/202316,460,000 shares $24.69 million +0.6%13.2%19.1 $1.50 5/15/202316,370,000 shares $19.64 million -3.1%13.1%24.5 $1.20 4/30/202316,890,000 shares $17.73 million +0.6%13.6%28.6 $1.05 4/15/202316,790,000 shares $18.13 million +2.2%13.6%29.7 $1.08 3/31/202316,430,000 shares $17.91 million +6.1%13.3%27.6 $1.09 3/15/202315,490,000 shares $15.64 million +2.9%12.5%24.9 $1.01 2/28/202315,050,000 shares $16.40 million -1.4%12.2%27.1 $1.09 2/15/202315,270,000 shares $17.71 million -2.9%12.4%29 $1.16[Urgent] Starlink Set For The Largest IPO In History? (Ad)He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again with Tesla… which is up more than 19,500% since 2010. For perspective, that turns $100 invested into almost $20,000! And now, Elon could be set to do it for the third and final time… with what might be his biggest breakthrough yet. And for the first time ever, you have the rare chance to profit BEFORE the upcoming IPO.Click here now for the urgent details on this hidden play. 1/31/202315,730,000 shares $18.09 million +3.8%11.7%32 $1.15 1/15/202315,150,000 shares $20.45 million -5.4%12.7%30.2 $1.35 12/30/202216,020,000 shares $17.30 million +0.4%33.0%36.9 $1.08 12/15/202215,960,000 shares $14.37 million -1.1%12.1%34.6 $0.90 11/30/202216,130,000 shares $16.78 million -1.7%12.2%35.1 $1.04 11/15/202216,400,000 shares $17.38 million +3.0%12.4%34.7 $1.06 10/31/202215,930,000 shares $18.48 million +3.6%12.0%33.8 $1.16 10/15/202215,380,000 shares $18.46 million +6.7%11.6%33.4 $1.20 9/30/202214,420,000 shares $17.59 million +5.6%10.9%30.8 $1.22 9/15/202213,660,000 shares $15.71 million +9.2%10.3%29.1 $1.15 8/31/202212,510,000 shares $14.01 million +2.6%9.4%26.3 $1.12 8/15/202212,190,000 shares $15.36 million -0.7%9.2%13.9 $1.26 7/31/202212,280,000 shares $13.88 million +4.0%9.3%12.9 $1.13 7/15/202211,810,000 shares $13.82 million +5.7%8.9%12.2 $1.17 6/30/202211,170,000 shares $11.39 million +4.7%8.4%11 $1.02 6/15/202210,670,000 shares $10.59 million -8.3%6.5%9 $0.99 5/31/202211,640,000 shares $13.39 million +4.2%7.1%8.3 $1.15 5/15/202211,170,000 shares $17.87 million +4.6%6.8%9.3 $1.60 4/30/202210,680,000 shares $16.55 million +1.0%6.5%8.7 $1.55 4/15/202210,580,000 shares $19.26 million +9.3%9.9%7.6 $1.82 3/31/20229,680,000 shares $17.23 million +48.9%N/A6.5 $1.78 3/15/20226,500,000 shares $11.51 million +8.5%N/A4.6 $1.77 2/28/20225,990,000 shares $9.76 million +9.3%4.9%4.5 $1.63 2/15/20225,480,000 shares $7.67 million +3.4%4.5%3.4 $1.40 1/31/20225,300,000 shares $7.53 million +25.0%4.4%3.2 $1.42 1/15/20224,240,000 shares $5.64 million -1.9%3.5%2.8 $1.33 12/31/20214,320,000 shares $5.88 million +0.9%3.5%3.2 $1.36 12/15/20214,280,000 shares $6.21 million +16.3%3.5%3.2 $1.45 11/30/20213,680,000 shares $5.56 million -41.6%4.0%2.8 $1.51 11/15/20216,300,000 shares $12.29 million -1.4%7.1%5.7 $1.95 10/29/20216,390,000 shares $13.23 million +8.7%7.2%7.1 $2.07 10/15/20215,880,000 shares $12.41 million -3.5%6.7%2 $2.11 9/30/20216,090,000 shares $13.22 million +8.2%6.9%2.1 $2.17 9/15/20215,630,000 shares $13.62 million -0.5%6.4%1.8 $2.42 8/31/20215,660,000 shares $15.62 million +1.4%6.4%1.8 $2.76 8/13/20215,580,000 shares $13.39 million +71.7%6.3%1.8 $2.40 7/30/20213,250,000 shares $7.35 million +3.2%3.7%1.1 $2.26 7/15/20213,150,000 shares $7.15 million -25.2%3.6%3.4 $2.27 6/30/20214,210,000 shares $10.48 million +214.2%4.8%4.2 $2.49 6/15/20211,340,000 shares $3.46 million +6.4%1.5%1.5 $2.58 5/28/20211,260,000 shares $3.38 million +15.6%1.4%1.3 $2.68 5/14/20211,090,000 shares $2.11 million +41.8%N/A1 $1.94 4/30/2021768,600 shares $1.79 million +155.3%N/A0.3 $2.33 4/15/2021301,100 shares $563,057.00 -34.1%N/A0.1 $1.87 3/31/2021457,100 shares $996,478.00 +30.8%N/A0.1 $2.18 3/15/2021349,500 shares $782,880.00 +20.8%N/A0.1 $2.24 2/26/2021289,400 shares $616,422.00 -67.3%N/A0.1 $2.13 2/12/2021884,100 shares $2.29 million -55.1%N/A0.2 $2.59 1/29/20211,970,000 shares $2.40 million +25.5%N/A0.5 $1.22 1/15/20211,570,000 shares $1.93 million -19.9%N/A1.8 $1.23Elon knows the truth, which is why they want him silenced (Ad)Elon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to humanity, there is a war being waged on Elon Musk. This war has nothing to do with X, Elon’s stance on immigration or his support for Donald Trump. Watch this new documentary and you’ll discover what Elon knows, 12/31/20201,960,000 shares $2.61 million -2.5%N/A2.1 $1.33 12/15/20202,010,000 shares $2.65 million -3.4%N/A2.3 $1.32 11/30/20202,080,000 shares $2.56 million -25.2%N/A2.3 $1.23 11/15/20202,780,000 shares $2.89 million -13.9%N/A1.7 $1.04 10/30/20203,230,000 shares $2.60 million +4.5%N/A1.7 $0.81 10/15/20203,090,000 shares $2.70 million +8.8%N/A1.4 $0.87 9/30/20202,840,000 shares $2.04 million +16.9%N/A1.1 $0.72 9/15/20202,430,000 shares $1.56 million -9.3%N/A0.8 $0.64 8/31/20202,680,000 shares $1.77 million +0.4%N/A0.7 $0.66 8/14/20202,670,000 shares $3.74 million +29.6%N/A0.8 $1.40 7/31/20202,060,000 shares $2.80 million -11.6%N/A0.7 $1.36 7/15/20202,330,000 shares $3.22 million +8.9%N/A0.8 $1.38 6/30/20202,140,000 shares $2.76 million -23.3%8.2%0.9 $1.29 6/15/20202,790,000 shares $3.12 million +29.8%14.3%1.6 $1.12 5/29/20202,150,000 shares $2.19 million +1.4%N/A2.1 $1.02 5/15/20202,120,000 shares $1.52 million -1.4%N/A2.8 $0.72 4/30/20202,150,000 shares $1.48 million -0.9%N/A4.1 $0.69 4/15/20202,170,000 shares $1.54 million -1.8%N/A4.1 $0.71 3/31/20202,210,000 shares $1.48 million +5.4%N/A4 $0.67 3/13/20202,097,400 shares $1.30 million +1.8%N/A5.6 $0.62 2/28/20202,060,000 shares $1.13 million -5.1%N/A2.2 $0.55 2/14/20202,170,000 shares $1.52 million +5.9%18.0%2 $0.70 1/31/20202,050,000 shares $1.60 million -21.2%17.0%2 $0.78 1/15/20202,600,000 shares $2.68 million +30.0%21.4%2.7 $1.03 12/31/20192,000,000 shares $2.08 million +13.6%18.3%2.3 $1.04 OTLK Short Interest - Frequently Asked Questions What is Outlook Therapeutics' current short interest? Short interest is the volume of Outlook Therapeutics shares that have been sold short but have not yet been closed out or covered. As of September 30th, traders have sold 2,950,000 shares of OTLK short. 19.37% of Outlook Therapeutics' shares are currently sold short. Learn More on Outlook Therapeutics' current short interest. What is a good short interest ratio for Outlook Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. OTLK shares currently have a short interest ratio of 13.0. Learn More on Outlook Therapeutics's short interest ratio. What is a good short interest percentage for Outlook Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 19.37% of Outlook Therapeutics' floating shares are currently sold short. Is Outlook Therapeutics' short interest increasing or decreasing? Outlook Therapeutics saw a increase in short interest in the month of September. As of September 30th, there was short interest totaling 2,950,000 shares, an increase of 19.4% from the previous total of 2,470,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Outlook Therapeutics' float size? Outlook Therapeutics currently has issued a total of 23,660,000 shares. Some of Outlook Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Outlook Therapeutics currently has a public float of 15,230,000 shares. How does Outlook Therapeutics' short interest compare to its competitors? 19.37% of Outlook Therapeutics' shares are currently sold short. Here is how the short interest of companies compare to Outlook Therapeutics: Brainstorm Cell Therapeutics Inc. (2.58%), Coherus BioSciences, Inc. (24.37%), Champions Oncology, Inc. (3.64%), Protara Therapeutics, Inc. (10.42%), Terns Pharmaceuticals, Inc. (8.30%), Corvus Pharmaceuticals, Inc. (3.44%), Altimmune, Inc. (31.59%), Larimar Therapeutics, Inc. (5.59%), Verve Therapeutics, Inc. (27.05%), Anavex Life Sciences Corp. (20.78%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.04 billion), AppLovin Co. ($2.69 billion), Nu Holdings Ltd. ($2.64 billion), Paychex, Inc. ($2.61 billion), Cencora, Inc. ($2.30 billion), Aptiv PLC ($2.09 billion), Moderna, Inc. ($2.09 billion), Tractor Supply ($2.04 billion), Coinbase Global, Inc. ($1.97 billion), and International Paper ($1.95 billion). View all of the most shorted stocks. What does it mean to sell short Outlook Therapeutics stock? Short selling OTLK is an investing strategy that aims to generate trading profit from Outlook Therapeutics as its price is falling. OTLK shares are trading up $0.08 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Outlook Therapeutics? A short squeeze for Outlook Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of OTLK, which in turn drives the price of the stock up even further. How often is Outlook Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including OTLK, twice per month. The most recent reporting period available is September, 30 2024. More Short Interest Resources from MarketBeat Related Companies Brainstorm Cell Therapeutics Short Interest Data Coherus BioSciences Short Interest Data Champions Oncology Short Interest Data Protara Therapeutics Short Interest Data Terns Pharmaceuticals Short Interest Data Corvus Pharmaceuticals Short Interest Data Altimmune Short Interest Data Larimar Therapeutics Short Interest Data Verve Therapeutics Short Interest Data Anavex Life Sciences Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:OTLK) was last updated on 10/25/2024 by MarketBeat.com Staff From Our Partnerstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligen...Traders Agency | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredNotice: Major payout due November 19th - are you on the list?On Tuesday, November 19, 2024 smart investors will collect their share of a $1.2 billion windfall... It's p...Behind the Markets | SponsoredNvidia is Pivoting to Solve Big Tech’s $1 Trillion ProblemTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | Sponsored625,000% GainThe recent pullback in the crypto markets has left many investors in full-on panic mode, convinced the bull ru...Crypto Swap Profits | SponsoredGold at $2,600... But This Stock Gives You More for Under $20Gold just soared over $2,600 an ounce. But what if I told you there's a way to get exposure to MORE than an...Monument Traders Alliance | SponsoredTrump or Kamala? It may come down to this strange twist…Could this be the key to America's second coming? A strange resurrection born in the hollers of Appalachia? ...Porter & Company | SponsoredNext opportunity for crypto millionsOctober isn't just another month in crypto. It's the launchpad for what could be the most explosive bull run i...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist My Default Watchlist Adding Outlook Therapeutics, Inc. You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Please log in to your account or sign up in order to add this asset to your watchlist. Share Outlook Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free OTLK Stock Alerts